Clinical Trial Update: Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of OPC-1085EL ophthalmic solution in healthy male volunteers has been completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• OPC-1085EL ophthalmic solution (OPC-1085EL)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2015-04-02